Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nyse  >  AbbVie Inc    ABBV

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
08/31/2015 09/01/2015 09/02/2015 09/03/2015 09/04/2015 Date
62.41(c) 60.5(c) 60.98(c) 61.58(c) 59.77(c) Last
15 581 121 12 703 188 12 044 504 11 777 372 9 216 770 Volume
-2.45% -3.06% +0.79% +0.98% -2.94% Change
More quotes
Financials ($)
Sales 2015 22 919 M
EBIT 2015 9 432 M
Net income 2015 6 311 M
Debt 2015 12 750 M
Yield 2015 3,35%
Sales 2016 26 351 M
EBIT 2016 11 208 M
Net income 2016 8 019 M
Debt 2016 13 222 M
Yield 2016 3,66%
PER 2015 16,91
PER 2016 12,70
EV / Sales 2015 5,00x
EV / Sales 2016 4,37x
Capitalization 101 932 M
More Financials
Company
AbbVie, Inc. is a research-based biopharmaceutical company.It engages in the discovery, development, manufacture and sale of a broad line of proprietary pharmaceutical products.The company's products are used to treat rheumatoid arthritis, psoriasis, Crohn's disease, HIV, cystic fibrosis... 
Sector
Pharmaceuticals
Calendar
10/30Earnings Release
More about the company
Surperformance© ratings of AbbVie Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ABBVIE INC
09/03 BRISTOL MYERS SQUIBB : U.S. FDA Accepts for Priority Review the Biologics Licens..
09/02 ABBVIE : New Findings in Lymphoma Described from AbbVie Inc. [Phase 1 study of t..
09/01DJBRISTOL MYERS SQUIBB : -Myers Myeloma Drug Accepted for FDA Review
09/01DJBRISTOL MYERS SQUIBB : -Myers Myeloma Drug Accepted for Priority Review
09/01 ABBVIE : U.S. Food and Drug Administration Accepts for Priority Review the Biolo..
08/31DJCBO finds patent-law change could cost health programs $1.3 billion
08/31 PFIZER : resists calls for greater clinical trial transparency
08/31 PFIZER : resists calls for greater clincal trial transparency
More news
Sector news : Biopharmaceuticals
09/04DJBayer Gives Green Light to Covestro IPO -- 2nd Update
09/04DJBayer Gives Green Light to Covestro IPO -- Update
09/04 DR REDDY LABORATORIES : . Reddy’s launches MINTOP PRO TM – ProcapilT..
More sector news : Biopharmaceuticals
4-Traders Strategies on ABBVIE INC 
02/13A likely recovery
More Strategies
News from SeekingAlpha
09/04 TACTICAL DIVIDEND GROWTH : Buying Biotech, Assessing Market Volatility
09/03 Can Top 10 Healthcare Dogs Average 25% Upsides And 27% Net Gains As Of Septem..
09/03 Coherus Bio on track with biosimilar programs
09/03 3 Merger Arbitrage Opportunities
09/03 Small-Cap Biotech Companies Looking To Find A Niche In The Rheumatoid Arthrit..


Comments 
Advertisement
Chart ABBVIE INC
Duration : Period :
AbbVie Inc Technical Analysis Chart | ABBV | US00287Y1091 | 4-Traders
Full-screen chart
Technical analysis trends ABBVIE INC
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions